Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00598078 · ClinicalTrials.gov registry record · Phase 2
Multiple-dose,Double-blind,Placebo-controlled Study of Sodium Oxybate in Patients With Essential Tremor
A Phase 2 study, sponsored by Jazz Pharmaceuticals.
- Completed
- Registry status
- Phase 2
- Development phase
- 19
- Enrollment target
NCT00598078 is a Phase 2 study that has completed, run by Jazz Pharmaceuticals. The registered enrollment target is 19 participants.
The verdict
NCT00598078, a Phase 2 study, has completed, sponsored by Jazz Pharmaceuticals.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 19 participants
- Enrollment target
Study Summary
To determine the relationship between drug plasma levels and safety, tolerability and efficacy in patients with essential tremors after dosing with Sodium oxybate
Interventions
- OTHER Placebo
- DRUG Sodium Oxybate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 19 participants |
| Start Date | 2007-12 |
| Est. Completion | 2008-12 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00598078
The ClinicalTrials.gov registry entry for NCT00598078 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 19 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Jazz Pharmaceuticals, which has 128 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT00598078 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00598078 about?
NCT00598078 is a clinical study titled "Multiple-dose,Double-blind,Placebo-controlled Study of Sodium Oxybate in Patients With Essential Tremor". To determine the relationship between drug plasma levels and safety, tolerability and efficacy in patients with essential tremors after dosing with Sodium oxybate
What is the current status of trial NCT00598078?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 19 participants. The study started on 2007-12. Estimated completion is 2008-12.
What interventions are being tested in trial NCT00598078?
The interventions under investigation include: Placebo (OTHER), Sodium Oxybate (DRUG).
Who is sponsoring clinical trial NCT00598078?
This trial is sponsored by Jazz Pharmaceuticals, which has 128 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.